By means of polymerase chain reaction , belatacept-treated patients were tested for cytomegalovirus , Epstein-Barr virus , BK virus , and JC virus infections monthly for 36 months , monthly for the first 6 months , and then quarterly for 36 months in cyclosporine-treated patients .